Two-Drug Combo May Be Safe for Melanoma Treatment - Health News - Health.com
Friday, May 18th, 2012Latest news:

WEDNESDAY, May 16 (HealthDay Tidings) — A prelude, first-stage bailiwick funded by a pharmaceutic fellowship shows hopeful results for an data-based double-drug therapy for melanoma.
The two drugs, known as dabrafenib and trametinib, appeared to holdup advance of the potentially baneful hide cancer with fewer slope effects than an existent dose called vemurafenib (Zelboraf).




